Use of pro-/synbiotics as prophylaxis in patients undergoing colorectal resection for cancer: A meta-analysis of randomized controlled trials

Clinics and Research in Hepatology and Gastroenterology

Volumn 37, Issue 4, 2013, Pages 406-415

  He, Dan ^a   Wang, Hai Yang ^a   Feng, Jing Yan ^a   Zhang, Ming Ming ^a   Zhou, Yong ^a   Wu, Xiao Ting ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

PROBIOTIC AGENT; SYNBIOTIC AGENT;

ABDOMINAL INFECTION; ANASTOMOSIS LEAKAGE; ARTICLE; BACTERIAL TRANSLOCATION; BACTERIUM COLONY; BIFIDOBACTERIUM LONGUM; CANCER PATIENT; CANCER SURGERY; CHEMOPROPHYLAXIS; COCHRANE LIBRARY; COLORECTAL SURGERY; DEFECATION; DIARRHEA; DRUG EFFICACY; ELECTIVE SURGERY; EMBASE; ENTEROBACTERIACEAE; HUMAN; INFECTIOUS COMPLICATION; INTESTINE OBSTRUCTION; LACTOBACILLUS; LACTOBACILLUS BULGARICUS; LENGTH OF STAY; MEDLINE; MESENTERY LYMPH NODE; META ANALYSIS; MORBIDITY; PERIOPERATIVE PERIOD; PNEUMONIA; POSTOPERATIVE INFECTION; RANDOMIZED CONTROLLED TRIAL (TOPIC); SURGICAL INFECTION; SURGICAL MORTALITY;

COLORECTAL NEOPLASMS; HUMANS; POSTOPERATIVE COMPLICATIONS; PROBIOTICS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SYNBIOTICS;

EID: 84883554879     PISSN: 22107401     EISSN: 2210741X     Source Type: Journal    
DOI: 10.1016/j.clinre.2012.10.007     Document Type: Article

References (47)

1. Jemal A., Siegel R., Xu J., Ward E. Cancer statistics, 2010. CA Cancer J Clin 2010, 60:277-300.
2. Wacha H., Hau T., Dittmer R., Ohmann C. Risk factors associated with intraabdominal infections: a prospective multicenter study. Langenbecks Arch Surg 1999, 384:24-32. Peritonitis Study Group.
3. Gill H.S., Rutherfurd K.J., Prasad J., Gopal P.K. Enhancement of natural and acquired immunity by Lactobacillus rhamnosus (HN001), Lactobacillus acidophilus (HN017) and Bifidobacterium lactis (HN019). Br J Nutr 2000, 83:167-176.
4. Barbut F., Meynard J.L. Managing antibiotic associated diarrhoea. BMJ 2002, 324:1345-1346.
5. Madsen K., Cornish A., Soper P., Mckaigney C., Jijon H., Yachimec C., et al. Probiotic bacteria enhance murine and human intestinal epithelial barrier function. Gastroenterology 2001, 121:580-591.
6. Macfarlane G.T., Cummings J.H. Probiotics, infection and immunity. Curr Opin Infect Dis 2002, 15:501-506.
7. Schrezenmeir J., de Vrese M Probiotics, prebiotics, and synbiotics-approaching a definition. Am J Clin Nutr 2001, 73:361S-364S.
8. Tsunoda A., Shibusawa M., Tsunoda Y., Watanabe M., Nomoto K., Kusano M. Effect of Lactobacillus casei on a novel murine model of abdominal sepsis. J Surg Res 2002, 107:37-43.
9. Seehofer D., Rayes N., Schiller R., Stockmann M., Muller A.R., Schirmeier A., et al. Supply of lactobacillus and fiber versus selective bowel decontamination: a controlled trial in liver transplant recipients. Transplantation 2002, 74:123-127.
10. Rayes N., Seehofer D., Hansen S., Boucsein K., Muller A.R., Serke S., et al. Early enteral supply of lactobacillus and fiber versus selective bowel decontamination: a controlled trial in liver transplant recipients. Transplantation 2002, 74:123-127.
11. Sugawara G., Nagino M., Nishio H., Ebata T., Takagi K., Asahara T., et al. Perioperative synbiotic treatment to prevent postoperative infectious complications in biliary cancer surgery: a randomized controlled trial. Ann Surg 2006, 244:706-714.
12. Nomura T., Tsuchiya Y., Nashimoto A., Yabusaki H., Takii Y., Nakagawa S., et al. Probiotics reduce infectious complications after pancreaticoduodenectomy. Hepatogastroenterology 2007, 54:661-663.
13. Anderson A.D., Mcnaught C.E., Jain P.K., Macfie J. Randomised clinical trial of synbiotic therapy in elective surgical patients. Gut 2004, 53:241-245.
14. Jeppsson B., Mangell P., Thorlacius H. Use of probiotics as prophylaxis for postoperative infections. Nutrients 2011, 3:604-612.
15. Jadad A.R., Moore R.A., Carroll D., Jenkinson C., Reynolds D.J., Gavaghan D.J., et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary?. Control Clin Trials 1996, 17:1-12.
16. Reddy B.S., Macfie J., Gatt M., Larsen C.N., Jensen S.S., Leser T.D. Randomized clinical trial of effect of synbiotics, neomycin and mechanical bowel preparation on intestinal barrier function in patients undergoing colectomy. Br J Surg 2007, 94:546-554.
17. Hao YM W.J. Clinic application of enteral microecopharmaceutics nutrition in the perioperation of colorectal cancer [in Chinese]. Chin J Curr Adv Gen Surg 2007, 10:324-327.
18. Li Y. A study of enteral econutrition in patients received surgery for colorectal cancer [in Chinese]. Medical Journal of Qilu 2008, 4:303-305.
19. Gianotti L., Morelli L., Galbiati F., Rocchetti S., Coppola S., Beneduce A., et al. A randomized double-blind trial on perioperative administration of probiotics in colorectal cancer patients. World J Gastroenterol 2010, 16:167-175.
20. Liu Z., Qin H., Yang Z., Xia Y., Liu W., Yang J., et al. Randomised clinical trial: the effects of perioperative probiotic treatment on barrier function and post-operative infectious complications in colorectal cancer surgery-a double-blind study. Aliment Pharmacol Ther 2011, 33:50-63.
21. Zhang J.W., Du P., Gao J., Yang B.R., Fang W.J., Ying C.M. Preoperative probiotics decrease postoperative infectious complications of colorectal cancer. Am J Med Sci 2012, 343:199-205.
22. Drouault-Holowacz S., Bieuvelet S., Burckel A., Cazaubiel M., Dray X., Marteau P. A double blind randomized controlled trial of a probiotic combination in 100 patients with irritable bowel syndrome. Gastroenterol Clin Biol 2008, 32:147-152.
23. Kajander K., Hatakka K., Poussa T., Farkkila M., Korpela R. A probiotic mixture alleviates symptoms in irritable bowel syndrome patients: a controlled 6-month intervention. Aliment Pharmacol Ther 2005, 22:387-394.
24. Geier M.S., Butler R.N., Howarth G.S. Inflammatory bowel disease: current insights into pathogenesis and new therapeutic options; probiotics, prebiotics and synbiotics. Int J Food Microbiol 2007, 115:1-11.
25. Furrie E., Macfarlane S., Kennedy A., Cummings J.H., Walsh S.V., O'Neil D.A., et al. Synbiotic therapy (Bifidobacterium longum/Synergy 1) initiates resolution of inflammation in patients with active ulcerative colitis: a randomised controlled pilot trial. Gut 2005, 54:242-249.
26. Imase K., Tanaka A., Tokunaga K., Sugano H., Ishida H., Takahashi S. Lactobacillus reuteri tablets suppress Helicobacter pylori infection--a double-blind randomised placebo-controlled cross-over clinical study. Kansenshogaku Zasshi 2007, 81:387-393.
27. Lievin-Le M.V., Sarrazin-Davila L.E., Servin A.L. An experimental study and a randomized, double-blind, placebo-controlled clinical trial to evaluate the antisecretory activity of Lactobacillus acidophilus strain LB against nonrotavirus diarrhea. Pediatrics 2007, 120:e795-E803.
28. Jain P.K., Mcnaught C.E., Anderson A.D., Macfie J., Mitchell C.J. Influence of synbiotic containing Lactobacillus acidophilus La5, Bifidobacterium lactis Bb 12, Streptococcus thermophilus, Lactobacillus bulgaricus and oligofructose on gut barrier function and sepsis in critically ill patients: a randomised controlled trial. Clin Nutr 2004, 23:467-475.
29. Kotzampassi K., Giamarellos-Bourboulis E.J., Voudouris A., Kazamias P., Eleftheriadis E. Benefits of a synbiotic formula (Synbiotic 2000Forte) in critically Ill trauma patients: early results of a randomized controlled trial. World J Surg 2006, 30:1848-1855.
30. Barraud D., Blard C., Hein F., Marcon O., Cravoisy A., Nace L., et al. Probiotics in the critically ill patient: a double blind, randomized, placebo-controlled trial. Intensive Care Med 2010, 36:1540-1547.
31. Forestier C., Guelon D., Cluytens V., Gillart T., Sirot J., De Champs C. Oral probiotic and trial of dietary fiber and Lactobacillus casei administration for prevention of colorectal tumors. Int J Cancer 2005, 116:762-767.
32. Ishikawa H., Akedo I., Otani T., Suzuki T., Nakamura T., Takeyama I., et al. Randomized trial of dietary fiber and Lactobacillus casei administration for prevention of colorectal tumors. Int J Cancer 2005, 116:762-767.
33. Rayes N., Hansen S., Seehofer D., Muller A.R., Serke S., Bengmark S., et al. Early enteral supply of fiber and Lactobacilli versus conventional nutrition: a controlled trial in patients with major abdominal surgery. Nutrition 2002, 18:609-615.
34. Mcnaught C.E., Woodcock N.P., Macfie J., Mitchell C.J. A prospective randomised study of the probiotic Lactobacillus plantarum 299V on indices of gut barrier function in elective surgical patients. Gut 2002, 51:827-831.
35. Kanazawa H., Nagino M., Kamiya S., Komatsu S., Mayumi T., Takagi K., et al. Synbiotics reduce postoperative infectious complications: a randomized controlled trial in biliary cancer patients undergoing hepatectomy. Langenbecks Arch Surg 2005, 390:104-113.
36. Rayes N., Seehofer D., Theruvath T., Mogl M., Langrehr J.M., Nussler N.C., et al. Effect of enteral nutrition and synbiotics on bacterial infection rates after pylorus-preserving pancreatoduodenectomy: a randomized, double-blind trial. Ann Surg 2007, 246:36-41.
37. Rayes N., Seehofer D., Theruvath T., Schiller R.A., Langrehr J.M., Jonas S., et al. Supply of pre- and probiotics reduces bacterial infection rates after liver transplantation-a randomized, double-blind trial. Am J Transplant 2005, 5:125-130.
38. Zhang M.M., Cheng J.Q., Lu Y.R., Yi Z.H., Yang P., Wu X.T. Use of pre-, pro- and synbiotics in patients with acute pancreatitis: a meta-analysis. World J Gastroenterol 2010, 16:3970-3978.
39. Pitsouni E., Alexiou V., Saridakis V., Peppas G., Falagas M.E. Does the use of probiotics/synbiotics prevent postoperative infections in patients undergoing abdominal surgery?. A meta-analysis of randomized controlled trials. Eur J Clin Pharmacol 2009, 65:561-570.
40. Backhed F., Ley R.E., Sonnenburg J.L., Peterson D.A., Gordon J.I. Host-bacterial mutualism in the human intestine. Science 2005, 307:1915-1920.
41. Rolfe R.D. The role of probiotic cultures in the control of gastrointestinal health. J Nutr 2000, 130:396S-402S.
42. Hempel S., Newberry S.J., Maher A.R., Wang Z., Miles J.N., Shanman R., et al. Probiotics for the prevention and treatment of antibiotic-associated diarrhea: a systematic review and meta-analysis. JAMA 2012, 307:1959-1969.
43. Mcfarland L.V. Systematic review and meta-analysis of Saccharomyces boulardii in adult patients. World J Gastroenterol 2010, 16:2202-2222.
44. De Groote M.A., Frank D.N., Dowell E., Glode M.P., Pace N.R. Lactobacillus rhamnosus GG bacteremia associated with probiotic use in a child with short gut syndrome. Pediatr Infect Dis J 2005, 24:278-280.
45. Besselink M.G., van Santvoort H.C., Buskens E., Boermeester M.A., van Goor H., Timmerman H.M., et al. Probiotic prophylaxis in patients with predicted severe acute pancreatitis: a randomised, double-blind, placebo-controlled trial. Ned Tijdschr Geneeskd 2008, 152:685-696.
46. Ritchie M.L., Romanuk T.N. A meta-analysis of probiotic efficacy for gastrointestinal diseases. PLoS One 2012, 7:e34938.
47. Rayes N., Seehofer D., Neuhaus P. Prebiotics, probiotics, synbiotics in surgery-are they only trendy, truly effective or even dangerous?. Langenbecks Arch Surg 2009, 394:547-555.